Worldwide prescription drug market only forecast to grow at a marginally faster rate than the medtech market. Evaluate consensus forecasts find that the worldwide market for prescription drugs is set to narrowly outperform the medical device market with a 5.2% market growth per year between 2016 and 2022, versus a 5.1% growth rate per year for medical devices.
Learning how to effectively communicate in any industry is invaluable and in the cross-border trade it is essential. The right communication methods inspire confidence and instill trust. We have compiled a list of some effective ways to improve communication in cross-border medical trade.
As we all know, participating in international exhibitions is one of the most important marketing methods and the first choice to gain access to new international markets for pharmaceutical companies. So if it’s your first time attending an international exhibition, you may find the following practical tactics useful.
Since the launch of the Ddu Global Promotion Plan, Ddu has succeeded in helping users do international product promotions without leaving home and has matched thousands of orders, rapidly gaining popularity in the medical trade industry.
Ddu, the leading global pharmaceutical and medical device B2B online platform, attended the 15th International Show for products, equipment and services for the healthcare sector (Expo Medical) held at Centro Costa Salguero, Buenos Aires, Argentina from September 27 to September 29 2017, impressing everyone at the exhibition with the brilliant company concept of “Internet + medical trade”.
The U.S. Food and Drug Administration(FDA) approved the FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that can be used by adult patients to make diabetes treatment decisions without calibration using a blood sample from the fingertip (often referred to as a “fingerstick”).
Merck (NYSE:MRK), known as MSD outside of the United States and Canada, announced its strategic decision to discontinue the development of the investigational combination regimens MK-3682B (grazoprevir/ruzasvir/ uprifosbuvir) and MK-3682C (ruzasvir/uprifosbuvir) for the treatment of chronic hepatitis C virus (HCV) infection.
The U.S. Food and Drug Administration(FDA) approved Verzenio (abemaciclib) to treat adult patients who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer that has progressed after taking therapy that alters a patient’s hormones (endocrine therapy).
LabAsia Kuala Lumpur is the LARGEST Lab Exhibition in Southeast Asia (SEA). LabAsia started its first step into the Indonesia market by launching LabIndonesia, which turn out to be a success. LabAsia and LabIndonesia are held biannually alternately.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.